Musculoskeletal
2 drugs are in development for Polymyalgia Rheumatica.
- Companies
- 1
- Clinical trials
- 5
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Polymyalgia Rheumatica pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 4(2)
| Drug | Company |
|---|---|
| sarilumab | Sanofi (SNY) |
| Sarilumab | Sanofi (SNY) |
About this indication
Polymyalgia Rheumatica context
Musculoskeletal·MeSH: Polymyalgia Rheumatica (D011111)
Also known as: Forestier Certonciny Syndrome, Peri-Extra-Articular Rheumatism
Frequently asked questions
How many drugs are in development for Polymyalgia Rheumatica?
BioSniper tracks 2 drugs in development for Polymyalgia Rheumatica across 1 company.
How many clinical trials target Polymyalgia Rheumatica?
There are 5 clinical trials targeting Polymyalgia Rheumatica tracked by BioSniper.